ONEMEDNET CORPORATION Capital Expenditures
ONEMEDNET CORPORATION (ONMD) reported Capital Expenditures of $11.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-14
- ONEMEDNET CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $9.00K, a 200.00% increase year-over-year.
- ONEMEDNET CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $2.00K, a 60.00% decline year-over-year.
- ONEMEDNET CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $5.00K, a 85.71% decline year-over-year.
- ONEMEDNET CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ONEMEDNET CORPORATION payments to acquire property, plant, and equipment for fiscal 2023 was $44.00K, a 24.14% decline from fiscal 2022.
- ONEMEDNET CORPORATION payments to acquire property, plant, and equipment for fiscal 2022 was $58.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9.00K derived: 10-Q 6 month − S-1/A 3 month · filed 2026-08-14 | $11.00K 10-Q · filed 2026-08-14 | $16.00K derived: sum of 3 quarters · filed 2026-08-14 | $16.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $2.00K S-1/A · filed 2026-07-08 | $7.00K derived: sum of 2 quarters · filed 2026-07-08 | $7.00K derived: sum of 3 quarters · filed 2026-07-08 | $10.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $5.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $5.00K derived: sum of 2 quarters · filed 2026-07-08 | $8.00K derived: sum of 3 quarters · filed 2026-08-14 | $13.00K S-1/A · filed 2026-07-08 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $3.00K derived: sum of 2 quarters · filed 2026-08-14 | $8.00K 10-Q · filed 2025-11-14 | $43.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $3.00K derived: 10-Q 6 month − S-1/A 3 month · filed 2026-08-14 | $8.00K 10-Q · filed 2026-08-14 | $43.00K derived: sum of 3 quarters · filed 2026-08-14 | $52.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $5.00K S-1/A · filed 2026-07-08 | $40.00K derived: sum of 2 quarters · filed 2026-07-08 | $49.00K derived: sum of 3 quarters · filed 2026-07-08 | $50.00K derived: sum of 4 quarters · filed 2026-07-08 | ||
| 2024-12-31 | $35.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $44.00K derived: sum of 2 quarters · filed 2026-07-08 | $45.00K derived: sum of 3 quarters · filed 2026-07-08 | $51.00K S-1/A · filed 2026-07-08 | ||
| 2024-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $10.00K derived: sum of 2 quarters · filed 2025-11-14 | $16.00K 10-Q · filed 2025-11-14 | $32.00K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $7.00K 10-Q · filed 2025-08-13 | $23.00K derived: sum of 3 quarters · filed 2025-08-13 | $44.00K derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $6.00K 10-Q · filed 2025-05-14 | $22.00K derived: sum of 2 quarters · filed 2025-05-14 | $43.00K derived: sum of 3 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $37.00K derived: sum of 2 quarters · filed 2025-04-15 | $44.00K 10-K · filed 2025-04-15 | $43.76K 10-K · filed 2024-04-09 | ||
| 2023-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | $28.00K 10-Q · filed 2024-12-17 | $28.80K 10-Q · filed 2023-11-20 | |||
| 2023-06-30 | $7.00K 10-Q · filed 2024-12-11 | |||||
| 2022-12-31 | $10.00K derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | $58.00K 10-K/A · filed 2024-11-05 | $58.14K 10-K · filed 2024-04-09 | |||
| 2022-09-30 | $48.00K 8-K/A · filed 2024-11-22 | $48.77K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |